HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexamethasone and interleukin-2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndrome.

Abstract
Interleukin-2 (IL-2) in combination with dexamethasone was administered to a 48-year-old man with renal cell carcinoma accompanied by paraneoplastic inflammatory syndrome, including progressive multiple lung metastases and inferior vena caval tumor thrombus. Although non-steroidal anti-inflammatory drugs had no apparent antipyretic effect on the systemic inflammatory syndrome, oral administration of dexamethasone achieved complete antipyresis and improved his quality of life. After a 4-week period of IL-2 treatment, regression of metastasized lesions was demonstrated despite concurrent oral administration of dexamethasone. Steroids might reduce the action of immunotherapeutic drugs, but in some cases, combination therapy can achieve both alleviation of the paraneoplastic syndrome and tumor shrinkage.
AuthorsToshiaki Shinojima, Mototsugu Oya, Hidaka Kohno, Ken Marumo, Masaru Murai
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 11 Issue 7 Pg. 553-6 (Jul 2004) ISSN: 0919-8172 [Print] Australia
PMID15242368 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Interleukin-2
  • Dexamethasone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Renal Cell (complications, drug therapy, pathology)
  • Dexamethasone (administration & dosage)
  • Disease Progression
  • Humans
  • Inflammation (drug therapy, etiology)
  • Interleukin-2 (administration & dosage)
  • Kidney Neoplasms (complications, drug therapy, pathology)
  • Male
  • Middle Aged
  • Paraneoplastic Syndromes (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: